Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Self-expression, happiness drive expansion of Selfie Boutique playground
What started as a side project four months ago has grown into a huge, interactive exhibit dedicated to cultivating joy, said Alex Altomare, founder of the Selfie Boutique. “The mission is to bring people together and create happiness,” Altomare said. “The growth has been entirely driven by our supporters on all fronts, and we have…
Brewers ferment market opportunity, health benefits with kombucha startups
Fermented foods represent more than just trendy, niche products, Kansas City’s kombucha startups say. They’re where gut health and market opportunity meet. “If it’s not local, it’s not fresh,” said Lisa Bledsoe, emphasizing the quality advantage Kansas City brewers have over national brands competing for cooler space at metro grocery stores. Bledsoe’s Tea-Biotics Kombucha has…
Applicants pour in for a chance at $500K in LaunchKC grants
Editor’s note: This article is sponsored by LaunchKC but was independently produced by Startland News. After dishing out $1.5 million to 29 startups over the last three years, LaunchKC returns in 2018 with more experience and an enduring determination to drive entrepreneurial impact in Kansas City. The area’s most-popular grants contest already has garnered hundreds…
Peek inside: Wild Way coffee rolling Austin flavor onto Kansas City’s bean scene
Christine Clutton is taking the rollout of her Wild Way coffee camper concept one cup at a time, she said. Debuting Friday in Midtown, the mobile shop — serving coffee, tea and pastries with a mix of Austin and local flavors — is envisioned as a temporary stop on Clutton’s entrepreneurial journey, she said. “Our…